CBPO China Biologic Products Inc.
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
- 25.94 P/E
- 7.12 P/S
- 8.36 P/B
- 2.538 EPS
- 40.69% Cash ROIC
- 2.38 Cash Ratio
- 0.00 / N/A % Dividend
- 68,672.00 Avg. Vol.
- 27.57M Shares
- 1.645B Market Cap.
China Biologic Products, Inc., a biopharmaceutical company, engages in the research, development, production, and manufacture of plasma-based pharmaceutical products in the People's Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and...
Seeking Alpha (registration) - Nov 6, 2014
Forbes - Oct 13, 2014
Zacks.com - Aug 27, 2014
Seeking Alpha (registration) - Aug 5, 2014
Seeking Alpha (registration) - Nov 11, 2014
PR Newswire (press release) - Nov 3, 2014
Seeking Alpha (registration) - Aug 11, 2014
Seeking Alpha - Oct 20, 2010
Zacks.com - Aug 19, 2014
StreetInsider.com (subscription) - Nov 19, 2012